CONMED Corporation (CNMD) Covered Calls

CONMED Corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services. The company’s products are used by surgeons and healthcare professionals across various specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. It is recognized for its leadership in minimally invasive surgical devices and smoke evacuation systems.

You can sell covered calls on CONMED Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CNMD (prices last updated Tue 1:35 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

CONMED Corporation (CNMD) is a diversified medical device manufacturer that provides essential equipment for the modern operating room. The company operates through two primary reporting segments: General Surgery and Orthopedics. Its General Surgery portfolio includes a robust line of endomechanical instrumentation, electrosurgical generators, and the proprietary AirSeal system, which is the world’s only integrated access system for robotic and laparoscopic surgery. The Orthopedics segment, primarily under the Linvatec brand, offers a comprehensive range of sports medicine products, powered surgical instruments, and tissue repair solutions.

The company’s growth strategy is built on a "sharpened strategic focus" that prioritizes high-margin, high-growth categories. In early 2026, CONMED completed a significant strategic pivot by exiting its lower-margin gastroenterology product line to concentrate resources on its core strengths in minimally invasive surgery and smoke evacuation. Revenue is generated through a global sales force that targets hospitals and ambulatory surgery centers (ASCs). With international sales showing double-digit growth in 2025, the firm is aggressively expanding its presence in the EMEA and Asia-Pacific regions. The organization maintains a disciplined capital allocation policy, recently suspending its dividend in favor of a $150 million share repurchase program to drive earnings per share (EPS) accretion throughout 2026.

Competitive Landscape

The medical technology sector is highly consolidated, with CONMED competing against multi-billion dollar conglomerates and specialized surgical firms. Competition is driven by clinical outcomes, ease of use, and the ability to integrate products with the growing trend of robotic-assisted surgery.

1. Merit Medical Systems: A primary competitor in the disposable medical device space, particularly in cardiology and radiology procedures.
2. Stevanato Group: Competes for institutional healthcare capital within the medical devices and life sciences infrastructure sector.
3. Envista Holdings: A peer in the medical technology sector that provides a benchmark for valuation and operational efficiency in specialized healthcare markets.
4. iRhythm Technologies: While focused on digital health, it competes with CNMD for allocation in the medical device sleeve of institutional portfolios.
5. Teleflex Incorporated: A major rival in the surgical and critical care markets, often competing for hospital-wide procurement contracts.

Strategic Outlook and Innovation

The strategic roadmap for 2026 targets reported revenue between $1.345 billion and $1.375 billion, representing organic growth of approximately 4.5% to 6%. Management is focused on leveraging its "AirSeal" and smoke evacuation technologies to capitalize on tightening global safety regulations regarding surgical plumes. By reducing back-order levels to a three-year low through supply chain improvements, the company is positioned to regain market share in its core orthopedic soft tissue repair business. The company also remains active in "tuck-in" M&A, seeking innovative technologies that can be seamlessly integrated into its existing surgical and orthopedic sales channels.

Innovation at CONMED is centered on the "In-Room Experience" for surgical teams. The company is rolling out enhanced versions of its Buffalo Filter smoke evacuation systems, which utilize advanced filtration to capture 99.9% of hazardous surgical smoke. In the Orthopedics segment, the firm is pioneering new bio-composite materials for sports medicine implants that promote faster biological healing. Furthermore, the integration of digital data captures within the AirSeal platform provides surgeons with real-time feedback on intra-abdominal pressure, enhancing patient safety during complex robotic procedures. These advancements are critical as CONMED seeks to transition from a hardware provider to a comprehensive partner in surgical performance and safety.

Want more examples? CNM Covered Calls | CNNE Covered Calls